Efficacy and Safety of Single-Pill Combination of Rosuvastatin and Ezetimibe in Chinese Patients with Primary Hypercholesterolemia Inadequately Controlled by Statin Treatment (ROZEL): A Randomized, Double-Blind, Double Dummy, Active-Controlled Phase 3 Clinical Trial

INTRODUCTION: Many patients with primary hypercholesterolemia do not achieve their plasma low-density lipoprotein cholesterol (LDL-C) goals with statin alone under a recommended dose of statin (e.g., 10 mg rosuvastatin) in China. The objective of this phase III study was to evaluate the efficacy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Qiaoli, Liu, Ying, Zhang, Guogang, Xu, Li, Wang, Min, Mei, Shifang, Garon, Genevieve, Wu, Yanzhen, Lv, Qiang, Ma, Changsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611639/
https://www.ncbi.nlm.nih.gov/pubmed/37770770
http://dx.doi.org/10.1007/s12325-023-02666-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611639/
https://www.ncbi.nlm.nih.gov/pubmed/37770770
http://dx.doi.org/10.1007/s12325-023-02666-z

Ejemplares similares